PharmaVoice 100

  • PharmaVoice 100 header
    Image attribution tooltip
    Illustration: Deena So Oteh for Industry Dive/PharmaVoice
    Image attribution tooltip

    The 2023 PharmaVoice 100

    This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.

    By • Sept. 19, 2023
  • leaders hands
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Catching up with 2022 PharmaVoice 100 honorees

    Tapping into our growing community for expertise and inspiration.

    By • Sept. 13, 2023
  • leadership
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    PharmaVoice 100

    The PharmaVoice 100 — Who makes the cut

    What we’re looking for in each new class of honorees.

    By • March 15, 2023
  • silhouette people
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    PharmaVoice 100 honorees: Where are they now?

    How some of our past PharmaVoice 100 honorees are transforming the life sciences industry in new roles. 

    By , • March 3, 2023
  • lightbulb breaking
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    Healthcare tech’s biggest busts

    The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.

    By • Dec. 2, 2022
  • pills
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    10 of our most popular articles in 2022

    Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.

    By • Nov. 30, 2022
  • Glen de Vries blue origin
    Image attribution tooltip
    Permission granted by Medidata
    Image attribution tooltip
    Q&A

    The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur

    Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.

    By • Nov. 11, 2022
  • brand
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    What’s your leadership brand?

    Pharma industry leaders share their brand personas.

    By • Oct. 14, 2022
  • Header of Peyton Howell with PV100 logo
    Image attribution tooltip
    Permission granted by Peyton Howell
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Peyton Howell

    The chief operating and growth officer of Parexel has sold her market access company and created award-winning DE&I programs, but it’s her role as “connector” that she takes the greatest pride in.

    By PharmaVoice staff • Sept. 15, 2022
  • Fabio Gratton header with PV100 logo
    Image attribution tooltip
    Permission granted by Fabio Gratton
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Fabio Gratton

    The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.

    By PharmaVoice staff • Sept. 15, 2022
  • Header image for Red Jacket Awards
    Image attribution tooltip
    Shaun Lucas/PharmaVoice
    Image attribution tooltip

    The 2022 Red Jacket honorees

    Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.

    Sept. 15, 2022
  • Udit Batra header with PV100 logo
    Image attribution tooltip
    Permission granted by Udit Batra
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Udit Batra

    A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.”

    By PharmaVoice staff • Sept. 15, 2022
  • A portrait of Jim Lang framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Lang
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Jim Lang

    The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.

    By PharmaVoice staff • Sept. 15, 2022
  • Quita Highsmith header
    Image attribution tooltip
    Permission granted by Quita Highsmith
    Image attribution tooltip
    Profile

    Red Jacket: Quita Highsmith

    The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.

    By PharmaVoice staff • Sept. 15, 2022
  • A portrait of Renata Campos framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Renata Campos
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Renata Campos

    Takeda's Growth and Emerging Markets Business Unit president is driving growth by doing what’s right for patients and her teams.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Samantha Du framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Samantha Du
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Samantha Du

    The CEO of Zai Lab is at the forefront of the movement to boost innovation in China’s biotech sector while delivering needed solutions to patients around the world.

    By • Sept. 6, 2022
  • A portrait of Lisa Walters-Hoffert framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lisa Walters-Hoffert
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Lisa Walters-Hoffert

    Daré Bioscience’s CFO and co-founder is determined to rapidly advance innovations in women’s health.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Jim Anthony framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Anthony
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Jim Anthony

    With a ready-for-anything attitude and a knack for relationship-building, the executive vice president and global head of Parexel Biotech is growing the CRO with a patient-first approach.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Armon Sharei framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Armon Sharei
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Armon Sharei

    The CEO of SQZ Biotech is leveraging a technology platform that is simple in its design yet targeted at making cell therapy to break down barriers to the treatments.

    By • Sept. 6, 2022
  • A portrait of Dr. Penelope Manasco framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Penelope Manasco
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Dr. Penelope Manasco

    How the NIH-trained scientist and CEO of MANA RBM is charting a new way forward in conducting clinical trials.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Dominique Demolle framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dominique Demolle
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Dominique Demolle

    How the CEO of Cognivia is revolutionizing drug development with psychonomics.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Kunal Ghosh framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kunal Ghosh
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Kunal Ghosh

    The leader of Inscopix embodies a 'bootstrap' approach to entrepreneurship, from soldering early versions of the Inscopix technology to taking a 'science-first' approach to fundraising.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Trishna Bharadia framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Trishna Bharadia
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Trishna Bharadia

    As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Jeff Fischer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jeff Fischer
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Jeff Fischer

    The co-founder and president led Longhorn Vaccines and Diagnostics to an unprecedented surge in production of its testing tech at the height of COVID-19 and is now pursuing a universal flu vaccine.

    By • Sept. 6, 2022
  • A portrait of Adrelia Allen framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Adrelia Allen
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Adrelia Allen

    Merck & Co.’s senior director of clinical trial patient diversity is transforming the pharma giant’s approach to inclusion and equality.

    By PharmaVoice staff • Sept. 6, 2022